Morgan Stanley Schedule 13G passive stakes

Morgan Stanley has filed an amended Schedule 13G, indicating its beneficial ownership in Treace Medical Concepts, Inc. has fallen to 3.4% as of December 31, 2024, no longer exceeding the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed beneficial ownership of 6.5% of Stoke Therapeutics, Inc.'s common stock as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, reporting a combined beneficial ownership in Radware Ltd., with the subsidiary's stake falling below the 5% threshold.

Morgan Stanley and its affiliates have filed an amended Schedule 13G, reporting a collective beneficial ownership of 5.3% in Western Asset Emerging Markets Debt Fund Inc. as of December 31, 2024.

Morgan Stanley has filed a Schedule 13G, revealing a beneficial ownership of 6.2% in Community Health Systems Inc. as of December 31, 2024.

Morgan Stanley has filed a Schedule 13G, revealing a passive beneficial ownership of 6.1% of BEYOND, INC.'s common stock as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G for Axogen, Inc., disclosing a 5.3% beneficial ownership by Morgan Stanley, while Morgan Stanley Capital Services LLC has ceased to be a beneficial owner of more than five percent of the common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed a beneficial ownership of 7.6% of Applied Therapeutics, Inc.'s common stock as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an amended Schedule 13G, revealing a combined beneficial ownership of 11.4% in Arbutus Biopharma Corp as of December 31, 2024.

Morgan Stanley has filed an amended Schedule 13G, disclosing a 5.4% beneficial ownership stake in Turning Point Brands, Inc. as of December 31, 2024.

Morgan Stanley has reported a 5.6% beneficial ownership stake in BBB Foods Inc. Class A Common Shares, while its subsidiary, Morgan Stanley Capital Services LLC, has reduced its stake to 4.3%, falling below the 5% reporting threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amended Schedule 13G, revealing a combined beneficial ownership of 6.5% in ClearBridge Energy Midstream Opportunity Fund Inc.'s common stock as of December 31, 2024.

Morgan Stanley and its investment management subsidiary have filed an amended Schedule 13G, indicating they are no longer beneficial owners of more than five percent of DoorDash, Inc.'s Class A Common Stock.

Morgan Stanley has filed a Schedule 13G, reporting a 5.4% beneficial ownership stake in C4 Therapeutics, Inc. as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a beneficial ownership of 8.6% in BlackRock Enhanced International Dividend Trust, totaling 8,243,916 common shares as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have reduced their beneficial ownership in abrdn Global Infrastructure Income Fund to 4.5%, ceasing to be a greater than 5% holder.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have reduced their beneficial ownership in abrdn Global Infrastructure Income Fund to 4.5%, ceasing to be a greater than 5% holder.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an updated Schedule 13G, disclosing their beneficial ownership of 8.1% of Affirm Holdings, Inc.'s Class A Common Stock as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have reported a reduction in their beneficial ownership of PGIM Short Duration High Yield Opportunities Fund's common shares to 4.7%, falling below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have disclosed a combined beneficial ownership of 6.7% of Playa Hotels & Resorts N.V.'s Ordinary Shares as of December 31, 2024, according to an amended Schedule 13G filing.

Morgan Stanley and its subsidiary, Parametric Portfolio Associates LLC, have jointly disclosed a beneficial ownership of 5.1% in Allspring Income Opportunities Fund, totaling 3,029,159 common shares.

Morgan Stanley has filed a Schedule 13G, reporting a 5.9% passive beneficial ownership stake in Coursera, Inc., holding over 9.3 million shares as of December 31, 2024.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed a beneficial ownership of 11.8% in BlackRock 2037 Municipal Target Term Trust, totaling 727,495 common shares.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have disclosed a combined beneficial ownership of 9.1% of Aurora Innovation, Inc.'s Class A Common Stock as of December 31, 2024, indicating a substantial passive investment.

Morgan Stanley and its subsidiary have filed a Schedule 13G, revealing beneficial ownership of 7.7% of Apellis Pharmaceuticals, Inc.'s common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have ceased to be beneficial owners of more than five percent of the common stock of Tortoise Midstream Energy Fund, Inc., reducing their stake to 0.0%.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an amendment to their Schedule 13G, indicating they are no longer beneficial owners of more than five percent of the common stock of Invesco High Income 2024 Target Term Fund.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have reported that their beneficial ownership in Bitfufu Inc. Class A Ordinary Shares has fallen below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have reported a reduction in their beneficial ownership of BILL Holdings, Inc. common stock, falling below the 5% reporting threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have reported a reduction in their beneficial ownership of Angel Oak Financial Strategies Income Term Trust's common shares to 3.5%, falling below the 5% threshold.